Enabling a traditional Australian medicinal plants agribusiness: - - PowerPoint PPT Presentation

enabling a traditional australian
SMART_READER_LITE
LIVE PREVIEW

Enabling a traditional Australian medicinal plants agribusiness: - - PowerPoint PPT Presentation

Enabling a traditional Australian medicinal plants agribusiness: From the land to the lab and back again; a pilot project Greg Leach & Dave Hewitt Menzies School of Health Research & Wild Orchard Kakadu Plum About the Traditional


slide-1
SLIDE 1

Enabling a traditional Australian medicinal plants agribusiness:

From the land to the lab and back again; a pilot project

Greg Leach & Dave Hewitt Menzies School of Health Research & Wild Orchard Kakadu Plum

slide-2
SLIDE 2

About the Traditional Medicinal Plants Project

  • Industry-Research-Indigenous Enterprise

collaboration

  • Development of sustainable, on-country

agribusiness based around native plants traditionally used for medicine

  • 18 month pilot project funded by the

Cooperative Research Centre for Developing Northern Australia (CRC-NA)

slide-3
SLIDE 3

Project Origins

slide-4
SLIDE 4

Project Context

  • Significant global market for natural medicines & health

products - US$83 billion pa

  • Good reputation of Australian natural health care products
  • Absence of products informed by Australian Indigenous

Traditional Knowledge

  • Lessons from Bush Foods industry
slide-5
SLIDE 5

Complementary Medicines

Regulated in Australia as medicines under the Therapeutic Goods Act 1989, complementary medicines include:

  • vitamins, mineral and nutritional supplements, homeopathic

products, aromatherapy products and herbal medicines.

  • The term ‘complementary medicines’ also comprises traditional

medicines, which includes traditional Chinese medicines, Ayurvedic, Australian Indigenous and Western herbal medicines.

  • $5.2 billion industry in Australia
slide-6
SLIDE 6

Complementary Medicines – export market

  • Australia has created a $1 billion export success story as consumer

demand continues to grow for high quality Australian complementary

  • medicines. Official exports of Complementary Medicines has trebled

in the last year.

  • 70% to China and Hong Kong
  • Australia has become the largest source of Nutrition and Health Food

Imports to China - significantly outcompeting the USA and Germany.

  • China represents a significant growth opportunity for the Australian

industry potentially doubling in size in 3 years

slide-7
SLIDE 7

Project Aims

  • Profile chemical, antimicrobial & anti-inflammatory

properties of some native Australian traditional medicinal plants

  • Engage Indigenous trainees and students in laboratory

based research

  • Develop prototype complementary healthcare products
  • Assess suitability for harvest on-country
  • Recognise Traditional Knowledge in Intellectual Property

management

  • Develop models for intellectual property management

& benefit sharing

slide-8
SLIDE 8

Indigenous Reference Group Project Partners & Project Governance Indigenous Enterprises Indigenous Steering Committee

Human Research Ethics Committee of the Northern Territory Department

  • f Health and Menzies School of Health Research
slide-9
SLIDE 9

Where are we?

slide-10
SLIDE 10

Project workshops

slide-11
SLIDE 11

Lab based research

slide-12
SLIDE 12

Training program

slide-13
SLIDE 13

Where to next

slide-14
SLIDE 14

Legal Requirements

Complex framework of laws, Treaties and Conventions at international, national and state/territory levels.

  • The Nagoya Protocol – International (UN) – important for export
  • Northern Territory Biological Resources Act (2006)
  • Research Access Agreements or Research permits on Aboriginal land
  • Parks & Wildlife Conservation Act – permit for taking wildlife
  • Section 19 Land Use Agreements – issued under ALRA.
slide-15
SLIDE 15

Concluding Comments

slide-16
SLIDE 16

Thanks & Acknowledgements

Child Health Division Indigenous Reference Group Medicinal Plants Project Steering committee Greg Leach Heidi Smith-Vaughn Robyn Marsh Mark Mayo Child Health Division Laboratory Group David Leach Hans Wohlmuth James de Voss Joanne Blanchfield Matheus Carpinelli de Jesus Desmond Sim Iftekhar Ahmed Yasmina Sultanbawa Ann Shanley Liz Webb We acknowledge the financial support of the Cooperative Research Centre for Developing Northern Australia and the support of its investment partners: the Western Australian, Northern Territory and Queensland Governments. We also acknowledge the financial and in-kind support of the project participants